Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine

Chin Med J (Engl). 2006 Mar 5;119(5):408-11.

Authors

Jing Wang¹, Chang-an Zhao, Kai Wang, Jin Zheng, Yi-li Wang, Lü-sheng Si

Affiliation

¹ Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute for Cancer Research, School of Life Science & Technology, Xi'an Jiaotong University, Xi'an 710061, China.

PMID: 16542585

No abstract available

MeSH terms

Adjuvants, Immunologic / administration & dosage*
Administration, Intranasal
Animals
Antibodies, Viral / blood
Bacterial Toxins / administration & dosage*
Capsid Proteins
Enterotoxins / administration & dosage*
Escherichia coli Proteins / administration & dosage*
Female
Hemagglutination Inhibition Tests
Human papillomavirus 16 / immunology*
Immunization
Interferon-gamma / biosynthesis
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Oncogene Proteins, Viral / genetics*
Oncogene Proteins, Viral / immunology
Papillomavirus Vaccines*
Vaccines, DNA / administration & dosage*
Vaccines, DNA / immunology
Viral Vaccines / administration & dosage*
Viral Vaccines / immunology
Virion / immunology

Substances

Adjuvants, Immunologic
Antibodies, Viral
Bacterial Toxins
Capsid Proteins
Enterotoxins
Escherichia coli Proteins
HPV L1 protein, Human papillomavirus
Oncogene Proteins, Viral
Papillomavirus Vaccines
Vaccines, DNA
Viral Vaccines
Interferon-gamma
heat-labile enterotoxin, E coli